Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized art initiation in a large urban HIV clinic in Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 2, 2012, Pages

  Hermans, Sabine M ^a,b,c   Castelnuovo, Barbara ^a   Katabira, Catherine ^a   Mbidde, Peter ^a   Lange, Joep M A ^b   Hoepelman, Andy I M ^c   Coutinho, Alex ^a   Manabe, Yukari C ^a,d  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV AIDS; Integrated TB HIV care; Operational research; Resource limited setting; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ETHAMBUTOL; ETHAMBUTOL PLUS ISONIAZID; ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; FEMALE; HEALTH CARE DELIVERY; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; UGANDA; URBAN AREA;

ADULT; AMBULATORY CARE FACILITIES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; UGANDA; URBAN POPULATION;

EID: 84862130064     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318251aeb4     Document Type: Article

References (27)

1. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-1021. (Pubitemid 36548927)
2. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science. 2010;328:856-861.
3. World Health Organization. Report on Global Tuberculosis Control. Geneva, Switzerland: World Health Organization; 2010.
4. World Health Organization. Interim Policy on Collaborative TB/HIV Activities. Geneva, Switzerland: World Health Organization; 2004.
5. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362: 697-706.
6. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365: 1492-1501.
7. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471-1481.
8. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482-1491.
9. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach 2010. Available at: http://www.who.int/entity/tb/publications/global-report/2010/en/ index.html. Accessed August 22, 2011.
10. Legido-Quigley H, Montgomery C, Khan PY, et al. Integrating tuberculosis and HIV services in low and middle-income countries: a systematic review. Trop Med Int Health. 2012; in press.
11. Uganda Ministry of Health. Annual health sector performance report. 2007/2008. Available at: http://health.go.ug/mohweb/. Accessed September 2, 2009.
12. Okot-Chono R, Mugisha F, Adatu F, et al. Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda. Int J Tuberc Lung Dis. 2009;13:955-961.
13. Uganda Ministry of Health. National Antiretroviral Treatment and Care Guidelines for Adults, Adolescents, and Children. Available at: http://www.who.int/hiv/amds/uganda-moh-treatment-guidelines.pdf. Accessed January 19, 2009.
14. National Tuberculosis Leprosy Programme, Uganda. Case Management Guidelines. 2007.
15. World Health Organization. Treatment of Tuberculosis Guidelines. Available at: http://www.who.int/entity/tb/publications/tb-treatmentguidelines/ en/index.html. Accessed April 13, 2010.
16. Miti S, Mfungwe V, Reijer P, et al. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS in Ndola, Zambia. Int J Tuberc Lung Dis. 2003;7: S92-S98. (Pubitemid 37162937)
17. Huerga H, Spillane H, Guerrero W, et al. Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis. 2010;14:611-615.
18. Phiri S, Khan PY, Grant AD, et al. Integrated tuberculosis and HIV care in a resource-limited setting: experience from the Martin Preusscentre, Malawi. Trop Med Int Health. 2011. doi: 10.1111/j.1365-3156.2011.02848.x.
19. International Union Against Tuberculosis and Lung Disease. Tuberculosis Control Assistance Program (TB-CAP)-Uganda. Achievements, challenges and lessons learned. 2007-2010. Available at: http://www.theunion.org/images/stories/What- We-do/TBCAP-Report-Online-ver-Final1.pdf. Accessed August 22, 2011.
20. Perumal R, Padayatchi N, Stiefvater E. The whole is greater than the sum of the parts: recognising missed opportunities for an optimal response to the rapidly maturing TB-HIV co-epidemic in South Africa. BMC Public Health. 2009;9:243.
21. Gasana M, Vandebriel G, Kabanda G, et al. Integrating tuberculosis and HIV care in rural Rwanda. Int. J. Tuberc. Lung Dis. 2008;12(3 suppl 1):39-43.
22. Castelnuovo B. A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci. 2010;10:320-324.
23. Nuwaha F. Control of tuberculosis in Uganda: a tale of two districts. Int J Tuberc Lung Dis. 1999;3:224-230. (Pubitemid 29133048)
24. Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002;6: 573-579. (Pubitemid 36898181)
25. Shargie EB, Lindtjorn B. Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007;4:e37.
26. Kaona FA, Tuba M, Siziya S, et al. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4:68.
27. Karim SA, Naidoo K, Grobler A, et al. Initiating ART during TB treatment significantly increases survival: results of a randomized controlled clinical trial in TB/HIV-co-infected patients in South Africa. Paper presented at: Conference of Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.